Defining Value When Launching Biosimilars Treatments Within European Healthcare Systems
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1677
https://www.valueinhealthjournal.com/article/S1098-3015(15)03753-5/fulltext
Title :
Defining Value When Launching Biosimilars Treatments Within European Healthcare Systems
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03753-5&doi=10.1016/j.jval.2015.09.1677
First page :
A535
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1105